Antineoplastic drug cytotoxicity in a human bladder cancer cell line: Implications for intravesical chemotherapy
暂无分享,去创建一个
C. Erlichman | C. Erlichman | D. Vidgen | A. Wu | D. Vidgen | A. Wu | W. A
[1] Y. Matsumura,et al. Intravesical Adriamycin chemotherapy in bladder cancer , 1983, Cancer Chemotherapy and Pharmacology.
[2] H. Green,et al. Two types of ribosome in mouse-hamster hybrid cells. , 1971, Nature: New biology.
[3] J. Richie,et al. Intravesical doxorubicin for prophylaxis in the management of recurrent superficial bladder carcinoma. , 1984, The Journal of urology.
[4] S. Loening,et al. Superficial bladder cancer: progression and recurrence. , 1983, The Journal of urology.
[5] W. Sadee,et al. Regulation of RNA- and DNA-directed actions of 5-fluoropyrimidines in mouse T-lymphoma (S-49) cells. , 1980, Cancer research.
[6] D. Kufe,et al. 5-Fluorouracil incorporation into human breast carcinoma RNA correlates with cytotoxicity. , 1981, The Journal of biological chemistry.
[7] J M Collins,et al. Pharmacologic rationale for regional drug delivery. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] B. Chabner. Pharmacologic principles of cancer treatment , 1982 .
[9] N. Walach,et al. Intravesical chemotherapy of superficial bladder tumors in a controlled trial with cis‐platinum versus Cis‐platinum plus hyaluronidase , 1985, Journal of surgical oncology.
[10] G. Prout,et al. Establishment and characterization of four human bladder tumor cell lines and sublines with different degrees of malignancy. , 1985, Cancer research.
[11] W. Frable,et al. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder. , 1981, The Journal of urology.
[12] B. Hill,et al. Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line , 2004, Urological Research.
[13] G. Prout,et al. Cell cycles in two cell lines of human bladder carcinoma. , 1977, The Tohoku journal of experimental medicine.
[14] R. Heimer,et al. Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism. , 1979, Science.
[15] D. Tolley,et al. Intravesical mitomycin C therapy for superficial bladder cancer. Report of a multicentre phase II study. , 1985, British journal of urology.
[16] F. Torti,et al. The biology and treatment of superficial bladder cancer. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.